To determine whether cellular compartmentalization of somatostatin receptors can be regulated in vivo, we examined the immunocytochemical distribution of the sst2A receptor (sst2AR) after stereotaxical injections of somatostatin analogs into the rat parietal cortex. Whereas CH-275, a sst1R agonist, failed to induce changes in the diffuse sst2AR immunostaining pattern characteristic of control animals, somatodendritic profiles displaying intracytoplasmic immunoreactive granules became apparent short-term after injection of either somatostatin or the sst2R agonist octreotide. Confocal microscopy revealed that 90% of sst2AR-immunoreactive endosome-like organelles displayed transferrin receptor immunoreactivity. At the electron microscopic level, the percentage of sst2AR immunoparticles dramatically decreased at the plasmalemma of perikarya and dendrites after octreotide injection. Conversely, it significantly increased in endosomes-like organelles. These results demonstrate that sst2ARs undergo, in vivo, rapid and massive internalization into the endocytic recycling compartment in response to acute agonist stimulation and provide important clues toward elucidating somatostatin receptor signaling in the mammalian brain.

Download full-text PDF

Source
http://dx.doi.org/10.1006/mcne.2000.0958DOI Listing

Publication Analysis

Top Keywords

sst2a receptor
8
somatostatin
5
vivo internalization
4
internalization somatostatin
4
somatostatin sst2a
4
receptor
4
receptor rat
4
rat brain
4
brain evidence
4
evidence translocation
4

Similar Publications

Altered nociception, a key feature of nociplastic pain, often involves central sensitization. We previously found that central sensitization underlying a nociplastic pain state in female mice depends on the ongoing activity of TRPA1 agonist-responsive afferents. Here, we investigated how the activity of these afferents induces and maintains central sensitization at the spinal level.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to examine the relationship between somatostatin receptor subtype 2A (SSTR2A) expression and genetic variants in adrenal and extra-adrenal paragangliomas (PGLs).
  • A total of 184 PGL patients were analyzed, revealing that 63.6% of tumors expressed SSTR2A, with SSTR2A-negative tumors more frequently being extra-adrenal and having higher rates of pathogenic variants (PVs).
  • The findings suggest a significant link between SSTR2A negativity, specific genetic mutations (particularly in VHL, FGFR1, and HRAS), and tumor location, emphasizing the importance of SSTR2A testing for personalized treatment approaches.
View Article and Find Full Text PDF

The somatostatin receptor 2A (SST2) is a G-protein-coupled receptor (GPCR) that is expressed in neuroendocrine tissues within the gastrointestinal tract and brain, and is commonly overexpressed in many neuroendocrine tumors. Moreover, SST2 agonists are used clinically as the primary pharmacological treatment to suppress excess hormone secretion in a variety of neuroendocrine tumors. Despite its wide clinical use, mechanisms controlling the trafficking and signaling of SST2 are not fully understood.

View Article and Find Full Text PDF

Neuropeptide Y in itch regulation.

Neuropeptides

December 2019

Department of Neuroscience, Uppsala University, 751 24 Uppsala, Sweden. Electronic address:

Itch is a somatosensory sensation that informs the organism about the presence of potentially harmful substances or parasites, and initiates scratching to remove the threat. Itch-inducing (pruritogenic) substances activate primary afferent neurons in the skin through interactions with specific receptors that converts the stimulus into an electrical signal. These signals are conveyed to the dorsal horn of the spinal cord through the release of neurotransmitters such as natriuretic polypeptide b and somatostatin, leading to an integrated response within a complex spinal interneuronal network.

View Article and Find Full Text PDF

Decompensation, a critical phase in the response to hemorrhage, is characterized by profound sympathoinhibition and the overriding of baroreflex mediated compensation. As sympathoexcitatory neurons of the rostral ventrolateral medulla (RVLM) maintain vasomotor tone and are essential for sympathetic baroreceptor reflex function, the RVLM is the likely mediator. However, how decompensation occurs is a mystery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!